Cystic Fibrosis: Engineered Proteins Can ‘Bypass’ Genetic Defect, University of Pittsburgh Study

ScienceDaily (Aug. 29, 2008) — By manipulating the machinery used by our cells for quality control, researchers from the University of Pittsburgh have found a way to restore the function of cystic fibrosis (CF) airway cells. This could significantly reduce the sticky mucus that plugs the lungs of CF patients, which leads to antibiotic-resistant infections and untimely death.

MORE ON THIS TOPIC